SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013562
Filing Date
2022-08-15
Accepted
2022-08-15 07:17:25
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akus-20220630x10q.htm   iXBRL 10-Q 1872471
2 EX-31.1 akus-20220630xex31d1.htm EX-31.1 16823
3 EX-31.2 akus-20220630xex31d2.htm EX-31.2 16816
4 EX-32.1 akus-20220630xex32d1.htm EX-32.1 13501
  Complete submission text file 0001558370-22-013562.txt   6481053

Data Files

Seq Description Document Type Size
5 EX-101.SCH akus-20220630.xsd EX-101.SCH 36370
6 EX-101.CAL akus-20220630_cal.xml EX-101.CAL 44830
7 EX-101.DEF akus-20220630_def.xml EX-101.DEF 138647
8 EX-101.LAB akus-20220630_lab.xml EX-101.LAB 361753
9 EX-101.PRE akus-20220630_pre.xml EX-101.PRE 272146
58 EXTRACTED XBRL INSTANCE DOCUMENT akus-20220630x10q_htm.xml XML 1089224
Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-410-1818
Akouos, Inc. (Filer) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39343 | Film No.: 221162305
SIC: 2834 Pharmaceutical Preparations